Simeprevir sodium
| CAS No. | 1241946-89-3 | Cat. No. | BCP18937 |
| Name | Simeprevir sodium | ||
| Synonyms | TMC 435 sodium salt;TMC 435 sodium; | ||
| Formula | C38H46N5NaO7S2 | M. Wt | 771.92 |
| Description | Simeprevir, also known as TMC435, is a drug for the treatment and cure of hepatitis C. In the United States, simeprevir is approved by the Food and Drug Administration for use in combination with peginterferon-alfa and ribavirin for hepatitis C and hepatitis B. Simeprevir has been approved in Japan for the treatment of chronic hepatitis C infection, genotype 1. | ||
| Pathways | Microbiology/Virology | ||
| Targets | HCV | ||
Structure
Part data of this page collected from the open network resources, so Biochempartner can not guarantee its accuracy.
For product details of different batches, please contact our Customer
- Service & Tech Support:orders@biochempartner.com
- Website:www.biochempartner.com
Products are for research use only and not for human use. We do not sell to patients.